Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
CDER
Biotech
Ovid eyes next chapter with CEO transition—Chutes & Ladders
Ovid's Levin set to become chairman as its next CEO stands ready. FDA’s oncology head takes top CDER post. Metagenomi shuffles CEO in reorg. Plus more.
Darren Incorvaia
,
Zoey Becker
Nov 14, 2025 8:30am
Fierce Pharma
FDA names oncology vet Pazdur as new CDER director
Nov 11, 2025 5:18pm
Fierce Pharma
George Tidmarsh exits as LinkedIn post sparks lawsuit, probe
Nov 3, 2025 11:13am
FDA proposes new approval pathway for rare diseases
Sep 3, 2025 1:20pm
Fierce Pharma
FDA taps new CDER chief as acting CBER head after Prasad exit
Jul 30, 2025 1:10pm
Fierce Pharma
FDA taps George Tidmarsh to lead CDER
Jul 21, 2025 10:53am